During the past decade, Kishiwada Tokushukai Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kishiwada Tokushukai Hospital" #1 collaborator was "Bard Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kishiwada Tokushukai Hospital" are "Alzheimer Disease" (2 trials) and "Critical Limb Ischemia" (1 trials). Many other conditions were trialed in "Kishiwada Tokushukai Hospital" in a lesser frequency.

Most popular intervention types in "Kishiwada Tokushukai Hospital" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gantenerumab" (2 trials), "Lutonix DCB" (1 trials), "Placebo" (1 trials) and "Uncoated PTA Catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kishiwada Tokushukai Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kishiwada Tokushukai Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kishiwada Tokushukai Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kishiwada Tokushukai Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".